Click to Share
 
 
  1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution
Filter News
Show All Results
News By Country
News By Tag
NeuroVax Remove


July 2014
Tu Mo Su Sa Fr Th We
22 21 20 19 18 17 16

NeuroVax Press Releases

  + XML/RSS  



By Immune Response BioPharma, Inc.
Immune Response BioPharma, Inc. Announces NeuroVax Granted Fast Track FDA Designation for SPMS

By Immune Response BioPharma Inc.
Immune Response BioPharma, Inc. Announces its Flagship Vaccine NeuroVax Granted Orphan Designation for Pediatric MS by the FDA.

By Immune Response BioPharma, Inc.
Immune Response BioPharma to Keep U.S. NeuroVax Rights for MS Expects Phase IIb Enrollment to Begin by Q2 2015.

By Immune Response BioPharma, Inc.
Immune Response BioPharma, Inc. Adopts Shareholder Rights Plan & Poison Pill Anti-Takeover Provision

All Press Releases

By Immune Response BioPharma, Inc.
Immune Response BioPharma, Inc. Announces NeuroVax Granted Fast Track FDA Designation for SPMS

By Immune Response BioPharma Inc.
Immune Response BioPharma, Inc. Posts 2nd Half & Full Year 2013 Results

By Immune Response BioPharma Inc.
Immune Response BioPharma, Inc. Announces its Flagship Vaccine NeuroVax Granted Orphan Designation for Pediatric MS by the FDA.

By Immune Response BioPharma, Inc.
Immune Response BioPharma to Keep U.S. NeuroVax Rights for MS Expects Phase IIb Enrollment to Begin by Q2 2015.

By Immune Response BioPharma, Inc.
Immune Response BioPharma, Inc. Selects the American Stock Transfer & Trust Company as Transfer Agent of Record.

By Immune Response BioPharma, Inc.
Immune Response BioPharma, Inc. Adopts Shareholder Rights Plan & Poison Pill Anti-Takeover Provision

By Immune Response BioPharma, Inc.
Immune Response BioPharma, Inc. Files for Orphan Designation for Blockbuster Drug NeuroVax for Multiple Sclerosis

By Immune Response BioPharma, Inc.
Immune Response BioPharma, Inc. Provides Business Update Sees Blockbuster MS Drug NeuroVax the Gold Standard of Care for MS and a Partnership by the end of Q1 2013

By Immune Response BioPharma, Inc.
Immune Response BioPharma, Inc. On the Move Plans Listing on German Exchanges to Fund Blockbuster MS Drug NeuroVax & Pipeline



Page updated every 10 minutes


  1. SiteMap
  2. Contact PRLog
  3. Privacy Policy
  4. Terms of Service
  5. Copyright Notice
  6. About
  7. Advertise
Like PRLog?
9K2K1K
Click to Share